You are here

Prices & Quotes - UK Markets - Diaceutics (DXRX)

Risk Warning The value of investments can fall as well as rise and any income from them is not guaranteed and you may get back less than you invested. Past performance is not a guide to future performance.

Share Price:
106.50p
Change Today:
0.000p
Market Cap:
89.53m
Sector:
Health Care Equipment & Services

Diaceutics wins data deal with unnamed pharma firm

By Josh White

Date: Thursday 01 Apr 2021

LONDON (ShareCast) - (Sharecast News) - Diaceutics has secured a data licensing agreement with an unnamed global pharmaceutical company to provide Covid-19 testing data insights in the US, it announced on Thursday, enabled by its proprietary diagnostic network 'DXRX'.
The AIM-traded company said that with around 400 treatments for the coronavirus now in development, the contract win- which came as a result of insights made available by its recent algorithmic development of a Covid-19 diagnostic disease pathway (DDP) - showed the group was in a position to address the "imminent opportunity" presented by the Covid-19 treatment market.

It said the details of the contract, including the identity of the pharmaceutical company and the value, were confidential, and no further information could be disclosed.

The board did say that the contract value did not change management expectations of performance for the current financial year.

"We are delighted to be able to facilitate access to this valuable Covid-tested patient cohort," said chief executive officer Peter Keeling.

"This first Covid-19 data-licensing agreement for the company provides testing data insights and analytics to pharmaceutical companies actively developing treatments for the disease.

"With hundreds of Covid-19 treatments now in development to address a pandemic at global scale, it is critically important that pharmaceutical companies lean in towards digital testing solutions such as those enabled by DXRX, to ensure that they have the data insights, and testing infrastructure required to get patients tested and treated."

At 1503 BST, shares in Diaceutics were up 1.57% at 103.6p.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Diaceutics Market Data

Currency UK Pounds
Price 106.50p
Change Today 0.000p
52 Week High 152.00p
52 Week Low 102.00p
Volume 0
Shares Issued 84.07m
Market Cap 89.53m
Beta 0.02

Performance Indicators

Compare performance with the sector and the market.

Key
Vs Market
Vs Sector
Value
market
  1. full market star
  2. full market star
  3. empty market
  4. empty market
  5. empty market
sector
  1. full sector star
  2. full sector star
  3. full sector star
  4. empty sector
  5. empty sector
Price Trend
market
  1. full market star
  2. empty market
  3. empty market
  4. empty market
  5. empty market
sector
  1. full sector star
  2. half sector star
  3. empty sector
  4. empty sector
  5. empty sector
Income
Not Available
Growth
market
  1. full market star
  2. half market star
  3. empty market
  4. empty market
  5. empty market
sector
  1. full sector star
  2. full sector star
  3. empty sector
  4. empty sector
  5. empty sector
Price Chg 6m
market
  1. full market star
  2. empty market
  3. empty market
  4. empty market
  5. empty market
sector
  1. full sector star
  2. full sector star
  3. empty sector
  4. empty sector
  5. empty sector
P/E
market
  1. empty market
  2. empty market
  3. empty market
  4. empty market
  5. empty market
sector
  1. empty sector
  2. empty sector
  3. empty sector
  4. empty sector
  5. empty sector
PEG
market
  1. full market star
  2. full market star
  3. full market star
  4. full market star
  5. half market star
sector
  1. full sector star
  2. full sector star
  3. full sector star
  4. full sector star
  5. half sector star
Dividend Yield
Not Available
EPS Growth
market
  1. half market star
  2. empty market
  3. empty market
  4. empty market
  5. empty market
sector
  1. empty sector
  2. empty sector
  3. empty sector
  4. empty sector
  5. empty sector
Operating Margin
market
  1. full market star
  2. half market star
  3. empty market
  4. empty market
  5. empty market
sector
  1. full sector star
  2. full sector star
  3. full sector star
  4. empty sector
  5. empty sector

Diaceutics Dividends

No dividends found

Trades

No recent trades found

Diaceutics Key Personnel

CEO Peter Keeling
CFO Philip Henry Hugh White